Neoruscogenin

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Neoruscogenin 因其相对于其他核受体的特定选择性而成为 RORα 研究的通用药理学工具。

Neoruscogenin represents a universal pharmacological tool for RORα research due to its specific selectivity profile versus other nuclear receptors.

Western Blot Analysis Cell Line:C2C12 myoblasts Concentration:0.1 μM Incubation Time:5 days Result:Increased protein expression of MyHC and MyOG at 0.1 μM, but did not work as well as 0.1 μM at 5 and 10 μM

Animal Model:male ICR mice Dosage:1 mg/kg Administration:i.p.Result:Showd the larger size of TA muscles, and increasaed the weight of Gas muscles.Showed visible myofibers hypertrophy (H&E staining).

——

Others

Other Targets

Others

——

——

17676-33-4

428.61

C27H40O4

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (116.66 mM)

C[C@]12CC[C@H]([C@@](C)([C@H](O)C[C@H](O)C3)C3=CC4)[C@@H]4[C@@H]1C[C@H]5[C@@H]2[C@H](C)[C@](O5)(CC6)OCC6=C

——

(-20℃)

With Ice Pack

≥ 2 years